久久久久女教师免费一区-久久久久女人精品毛片-久久久久女人爽女人爽-久久久久欧美激情-久久久久欧美精品-久久久久琪琪精品色

dynamic
動態

轉自美聯社:BON Announces Revolutionary Postbiotic Blood Sugar Solution Nears Patent Launch

2025-03-28

Bon Natural Life Limited (Nasdaq: BON) (“BON” or the “Company”), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced on Thursday, March 20 that a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar was gearing up for release.

Yongwei Hu, CEO & Chairman of BON, said “Backed by a robust IP strategy, BON is aggressively pursuing global patent protection. Over the next two years, we plan to lock down approvals across top markets, safeguarding our innovation while positioning ourselves for long-term dominance in the fast-growing metabolic health space. This strategic move not only shields the technology but also primes the business for scalable revenue growth and investor appeal.”

As China pushes its Healthy China 2030 agenda, the health industry is riding a sustained growth wave. According to iiMedia Data, a local authoritative third-party data monitoring institution, the market size of China’s health food products industry in 2023 exceeded 328 billion RMB ($45.5 billion), and is expected to reach 423.7 billion RMB ($58.8 billion) by 2027. Among them, vitamins and dietary supplements (VDS) account for over half of the total market. While China’s VDS spending per capita remains 22% of the U.S. levels, analysts project accelerated demand driven by aging demographics and preventive healthcare trends.

BON is positioning itself at the forefront of this fastest-growing industry. A strategic partnership built on March 9 with China’s agricultural giant Sanzhuliang Group Co., Ltd. signals BON’s ambition to bridge farming and biotech. The collaboration, facilitated by the Listed Companies Division of Commercial Culture Association of China, will focus on biotech innovation, functional food R&D, smart agriculture, industry standards, and more. An expert workstation under the Division was launched at BON’s headquarters to advance digital transformation and promote traditional Chinese medicine globally.

The Company’s recent stock surge underscores investor confidence in its leadership in China’s trillion-dollar functional food market. On Friday, March 14, BON stock skyrocketed over 300%, triggering multiple trading halts. Days later, BON priced a best efforts offering of $12 million, before deducting placement agent fees and other estimated expenses payable by the Company. BON intends to use the net proceeds from this offering for R&D, product expansion, global marketing and other corporate purposes.

As one of the few suppliers of stachyose, an extract from stachy affinis and also a prebiotic that can promote human intestinal health, BON has built an international footprint with products sold across Asia, the U.S., and the EU. Its portfolio includes stachyose, apple polyphenols, broccoli extracts, and proprietary formulations like probiotic powder drinks and micro-eco repair shampoos.

About Bon Natural Life Limited (“BON”)

BON is a Cayman Islands company engaged in the business of natural, health, and personal care industries. For more information, please visit the Company’s website at http://www.bnlus.com.

文章來源:美聯社https://www.universalpressrelease.com/?pr=bon-announces-revolutionary-postbiotic-blood-sugar-solution-nears-patent-launch


推薦新聞

主站蜘蛛池模板: 国产欧美日韩在线观看 | 97视频免费 | 欧美影院久久 | 97在线视频99播放 | 欧美特级大片 | 久久午夜一区二区 | 色综合五月激情综合色一区 | 奇米4色| 97影院午夜午夜伦不卡 | 九九精品视频在线 | 日日干天天操 | 欧美理论在线观看 | 大尺度视频网站久久久久久久久 | 午夜看一级特黄a大片黑 | 青青久久精品 | www午夜| 免费一级欧美大片视频在线 | 国产精品国产三级国快看 | 国产伦精品一区二区三区 | 亚洲欧美韩国 | 成人午夜天 | 日本精品a在线 | 国产爱久久久精品 | 九九网站| 我不卡老子影院午夜伦我不卡四虎 | h视频在线观看免费网站 | 亚洲欧美高清在线 | 成人国产精品免费视频 | 久久精品综合国产二区 | 色偷偷亚洲精品一区 | 曰本毛片va看到爽不卡 | 欧美成人香蕉在线观看 | 伊人95| 精品伊人久久 | 一级a级毛片| 九九99九九视频在线观看 | 久久精品国语 | 国产日韩在线播放 | 日韩免费视频一区二区 | 就操视频 | 中文字幕日本一区波多野不卡 |